tenecteplasetenecteplase-treatedalteplasestrokeAISClinicalTrials gov. NCT04797013IVT
…e and renal impairment complications, particularly for the drug tenecteplase. Therefore, we examined the association of impaired renal funct…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 291 of 2459ruxolitinibCryptococcal meningitismyelofibrosisanti-NMDAr encephalitisamphotericin Bflucytosinetertiary centreED
…Background Cryptococcal meningitis associated with ruxolitinib use in patients with myelofibrosis is rare. Furthermore, concom…
leflunomideadalimumabmethotrexatesekukinumabmultiple sclerosisnatalizumaboral prednisoloneIV methylprednisolonepsoriatic arthritisMS
…ucing his pre-existing immunosuppression (ceasing methotrexate, leflunomide and oral prednisolone). A repeat MRI brain demonstrated signifi…
TolebrutinibocrelizumabPPMSsecondary progressive MSprimary progressive MSPERSEUSNCT04458051
…Background Tolebrutinib, an oral, brain-penetrant, bioactive Bruton’s tyrosine kinase i…
cerebral amyloid angiopathyhigh dose steroid therapyCerebral amyloid angiopathy-related inflammationCAARICerebral amyloid angiopathy related inflammation
… C, Brown RD Jr, Christianson T, Hunder GG. Imaging findings of cerebral amyloid angiopathy, aβ-related angiitis (ABRA), and cerebral amyloid angiopathy-re…
98.7%
COVID-19ofatumumabappendicitisOMBUTIherpes viral infectionspwRMS
….84%) had 130 SIs over 6 years. Most commonly reported SIs were COVID-19 (n=49; 2.49%), UTI (n=16; 0.81%), lower RTI (n=16; 0.81%), and …
myasthenia gravisinflammatory meningitisChronic GvHDallo-HSCTBickerstaff brainstem encephalitisacute disseminated encephalomyelitisAllogeneic haematopoietic stem cell transplantgraft versus host diseaseGvHDmajor Australian institution
…have neurological complications. Four cases, each consisting of myasthenia gravis, Bickerstaff brainstem encephalitis (BBE), acute disseminated e…
Golimumabinflammatory bowel diseaseinflammatory arthritisuveitisOptic neuritismultiple sclerosisankylosing spondylitisMOG antibody diseaseneuromyeltis optica
… only two published case reports of optic neuritis secondary to Golimumab immunosuppression.…
denguetertiary care hospitalFFP
…od spanning January 2015 to March 2023.Results Among transfused dengue cases, blood groups O (41.71%), A (28.14%) and B (23.12%) were …
DuloxetinechemotherapyCIPN
…otherapy cessation and chronic, disabling neuropathic symptoms. Duloxetine has previously demonstrated efficacy for symptom relief, howeve…
Visual Analogue Scalehip fracturemultimodal analgesiasubtrochanteric fracturesfemoral neck
… those in the control group. Primary outcomes were pain scores (visual analog scale: 6 hours, 12 hours, 24 hours, and 48 hours postoperatively) and…
CRCantithrombotic therapycolorectal cancerdiverticulosisantiplateletsanticoagulantsantithrombotics
…se findings support the continued use of antithrombotics during CRC screening, shifting clinical interpretation from medication-bas…